These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32765477)

  • 41. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reconstitution of an infectious human endogenous retrovirus.
    Lee YN; Bieniasz PD
    PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines.
    Tatkiewicz W; Dickie J; Bedford F; Jones A; Atkin M; Kiernan M; Maze EA; Agit B; Farnham G; Kanapin A; Belshaw R
    Mob DNA; 2020; 11():9. PubMed ID: 32055257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites.
    Montesion M; Williams ZH; Subramanian RP; Kuperwasser C; Coffin JM
    Retrovirology; 2018 Aug; 15(1):57. PubMed ID: 30126415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations.
    Macfarlane C; Simmonds P
    J Mol Evol; 2004 Nov; 59(5):642-56. PubMed ID: 15693620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
    Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
    Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
    Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
    J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2).
    Hohn O; Mostafa S; Norley S; Bannert N
    J Virol Methods; 2016 Aug; 234():186-92. PubMed ID: 27142113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
    Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
    Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.
    Hanke K; Hohn O; Bannert N
    APMIS; 2016; 124(1-2):67-87. PubMed ID: 26818263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypermutation of an ancient human retrovirus by APOBEC3G.
    Lee YN; Malim MH; Bieniasz PD
    J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications.
    Mayer J; Stuhr T; Reus K; Maldener E; Kitova M; Asmus F; Meese E
    J Mol Evol; 2005 Nov; 61(5):706-15. PubMed ID: 16211423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer.
    Dolci M; Favero C; Toumi W; Favi E; Tarantini L; Signorini L; Basile G; Bollati V; D'Alessandro S; Bagnoli P; Ferrante P; Delbue S
    Front Oncol; 2020; 10():569015. PubMed ID: 33194657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.
    Reus K; Mayer J; Sauter M; Scherer D; Müller-Lantzsch N; Meese E
    Genomics; 2001 Mar; 72(3):314-20. PubMed ID: 11401447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions.
    Costa B; Vale N
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3.
    Fuchs NV; Kraft M; Tondera C; Hanschmann KM; Löwer J; Löwer R
    J Virol; 2011 Apr; 85(7):3436-48. PubMed ID: 21248046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
    Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
    Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and association study with lung cancer for novel insertion polymorphisms of human endogenous retrovirus.
    Kahyo T; Tao H; Shinmura K; Yamada H; Mori H; Funai K; Kurabe N; Suzuki M; Tanahashi M; Niwa H; Ogawa H; Tanioka F; Yin G; Morita M; Matsuo K; Kono S; Sugimura H
    Carcinogenesis; 2013 Nov; 34(11):2531-8. PubMed ID: 23872666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human endogenous retroviruses and cancer.
    Gonzalez-Cao M; Iduma P; Karachaliou N; Santarpia M; Blanco J; Rosell R
    Cancer Biol Med; 2016 Dec; 13(4):483-488. PubMed ID: 28154780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.